Inovio Pharmaceuticals, Inc.
(NASDAQ : INO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
ABTAbbott Laboratories
1.03%84.800.8%$425.62m
MDTMedtronic PLC
1.00%102.770.6%$421.61m
TMOThermo Fisher Scientific Inc.
1.01%276.081.0%$389.59m
ALGNAlign Technology, Inc.
1.68%177.296.3%$345.04m
ISRGIntuitive Surgical, Inc.
-0.88%495.452.4%$306.57m
BDXBecton, Dickinson and Company
0.78%248.261.1%$264.67m
SYKStryker Corporation
0.79%216.991.3%$231.95m
EWEdwards Lifesciences Corporation
1.93%219.371.2%$226.79m
BSXBoston Scientific Corporation
0.67%42.151.1%$221.88m
BAXBaxter International Inc.
1.36%86.951.7%$206.72m
ZBHZimmer Biomet Holdings, Inc.
1.38%137.001.7%$202.42m
ABMDABIOMED, Inc.
0.50%193.013.3%$153.08m
DXCMDexCom, Inc.
3.25%163.688.3%$150.35m
WATWaters Corporation
1.62%205.543.8%$116.40m
IDXXIDEXX Laboratories, Inc.
0.86%275.413.7%$111.67m

Company Profile

Inovio Pharmaceuticals, Inc. is a late-stage biotechnology company, which engages in the discovery, development, and commercialization of DNA-based immunotherapies and vaccines. Its drug candidates include SynCon immunotherapies which helps break the immune system's tolerance of cancerous cells; and CELLECTRA delivery system which facilitates optimized cellular uptake of the SynCon immunotherapies. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.